Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians Snow V; Qaseem A; Barry P; Hornbake ER; Rodnick JE; Tobolic T; Ireland B; Segal J; Bass E; Weiss KB; Green L; Owens DKAnn Fam Med 2007[Jan]; 5 (1): 74-80Venous thromboembolism is a common condition affecting 7.1 persons per 10,000 person-years among community residents. Incidence rates for venous thromboembolism are higher in men, African-Americans, and increase substantially with age. It is critical to treat deep venous thrombosis at an early stage to avoid development of further complications, such as pulmonary embolism or recurrent deep venous thrombosis. The target audience for this guideline is all clinicians caring for patients who have been given a diagnosis of deep venous thrombosis or pulmonary embolism. The target patient population is patients receiving a diagnosis of pulmonary embolism or lower-extremity deep venous thrombosis.|Cost-Benefit Analysis[MESH]|Female[MESH]|Fibrinolytic Agents/economics/*therapeutic use[MESH]|Heparin, Low-Molecular-Weight/economics/*therapeutic use[MESH]|Heparin/economics/therapeutic use[MESH]|Humans[MESH]|Pregnancy[MESH]|Pregnancy Complications, Cardiovascular/prevention & control[MESH]|Recurrence[MESH]|Stockings, Compression[MESH]|Thromboembolism/economics/*therapy[MESH]|Thrombolytic Therapy[MESH]|Vena Cava Filters[MESH]|Venous Thrombosis/economics/*therapy[MESH]|Vitamin K/antagonists & inhibitors[MESH] |